Tian'an Pharmaceutical Co., Ltd.

OTCPK:TNPH Stock Report

Market Cap: US$858.1k

Tian'an Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jianjun Weng

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure23.4yrs
CEO ownershipn/a
Management average tenure21.9yrs
Board average tenure21.1yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Jianjun Weng (68 yo)

23.4yrs
Tenure

Weng Jianjun has been Chief Executive Officer of Tian'an Pharmaceutical Co. Ltd. since January 2003. Mr. Weng has been the Chief Executive Officer of Xi'an Gelin Science and Technology Limited Company sinc...

Leadership Team

NamePositionTenureCompensationOwnership
Jianjun Weng
Chief Executive Officer and Director23.4yrsno datano data
Lie Wei
Chief Financial Officer and Chief Accounting Officerno datano datano data
Huachu Tang
Chief Investment Officer21.8yrsno datano data
Andong Jia
Chief Administration Officer21.6yrsno datano data
Peng Xi
Chief Marketing Officer22.1yrsno datano data
21.9yrs
Average Tenure
65yo
Average Age

Experienced Management: TNPH's management team is seasoned and experienced (21.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jianjun Weng
Chief Executive Officer and Director23.4yrsno datano data
Yanqing Wang
Independent Director20.3yrsUS$4.46kno data
Hongwei Wang
Director23.4yrsUS$4.46kno data
Ping Ren
Independent Director20.3yrsUS$4.46kno data
Zhiguo Ma
Independent Director21.1yrsUS$4.46kno data
Dingbang Liang
Independent Director20.3yrsUS$4.46kno data
Deshun Li
Director22.4yrsno datano data
Ning Jia
Director23.4yrsUS$4.46kno data
Yanming He
Independent Director21.1yrsUS$4.46kno data
Gao Jinming
Director18.4yrsno datano data
21.1yrs
Average Tenure
68yo
Average Age

Experienced Board: TNPH's board of directors are seasoned and experienced ( 21.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 18:58
End of Day Share Price 2026/05/26 00:00
Earnings2007/12/31
Annual Earnings2007/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tian'an Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.